Pavan Kumar Tupakula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pavan Kumar Tupakula has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Nagaraju Rakesh
Department of Oral Medicine and Radiology, Faculty of Dental Sciences, M.S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India
5 shared publications - Sujatha Sampige Reddy
Department of Oral Medicine and Radiology, Faculty of Dental Sciences, M.S. Ramaiah University of Applied Sciences, Bengaluru, India
4 shared publications - Priyadharshini Ramakrishnan
Pharmalytics Group, Vancouver, Canada
3 shared publications - V. Shwetha
Department of Oral Medicine, Radiology, Faculty of Dental Sciences, Ramaiah University of Applied Sciences, India
3 shared publications - Fabina Sharma Laipubam
Fabdontics Dental Care, Imphal, India
2 shared publications Rizwana Azmi
Department of Oral Medicine and Radiology, Ramaiah University of Applied Sciences, Bangalore, Karnataka, India
2 shared publications
Latest Publications
- Open Access
- 22 December 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (6) , 1109-1123
Identification of salivary volatile organic compounds as the potential diagnostic markers of oral cancer by the gas chromatography–mass spectrometry analysis
Oral cancer (OC) is a major public health problem in the Indian subcontinent. As many as 90% of all OC cases are oral squamous cell carcinomas (OSCCs), often developing from oral potentially malignant disorders (OPMDs). Although the oral cavity is freely accessible, visual identification is often challenging. Biopsy and a microscopic examination is the only confirmatory diagnostic test. Recently, the analysis of volatile organic compounds (VOCs) has emerged as a new, non-invasive, rapid, and inexpensive strategy with promising potential in clinical diagnostics. The human VOCs produced in metabolic pathways, present in body fluids and the exhaled air, can be used for monitoring several oral diseases, including OC. The aim of the present study was to determine the potential diagnostic capabilities of salivary VOCs in OC through identifying and comparing the salivary volatilomic profiles among OSCC and OPMD subjects, as well as healthy controls, using the gas chromatography-mass spectrometry (GC-MS) analysis. Unstimulated saliva samples were collected from 35 OSCC subjects, 35 OPMD subjects and 40 healthy controls. The VOCs extracted from the ZSM-5/PDMS film were condensed with 100 μL of methanol, of which 1.0 μL was subjected to the GC-MS analysis. A total of 128 salivary VOCs were detected and identified among the OSCC and OPMD subjects and the healthy controls. Twenty-five metabolites were determined to be statistically significant in differentiating among the 3 groups. Organic acids, alcohols, ketones, alkanes, and acid amides were the major classes of VOCs in the OSCC subjects, while organic acids, alcohols, ketones, acid amides, heterocyclic compounds, and phenols constituted the VOC profile in the OPMD subjects. 1-chloro-dodecane and 1-tridecanol were significant VOCs observed among the controls. The study demonstrates that salivary VOC profiling can reveal distinct metabolomic alterations in OSCC and OPMDs, with several VOCs emerging as potential tumor-specific biomarkers. While these findings highlight the promise of VOC-based screening, larger studies are needed to validate these markers and establish their clinical applicability.
- 22 December 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (6) , 1109-1123
Open AccessIdentification of salivary volatile organic compounds as the potential diagnostic markers of oral cancer by the gas chromatography–mass spectrometry analysis
Oral cancer (OC) is a major public health problem in the Indian subcontinent. As many as 90% of all OC cases are oral squamous cell carcinomas (OSCCs), often developing from oral potentially malignant disorders (OPMDs). Although the oral cavity is freely accessible, visual identification is often challenging. Biopsy and a microscopic examination is the only confirmatory diagnostic test. Recently, the analysis of volatile organic compounds (VOCs) has emerged as a new, non-invasive, rapid, and inexpensive strategy with promising potential in clinical diagnostics. The human VOCs produced in metabolic pathways, present in body fluids and the exhaled air, can be used for monitoring several oral diseases, including OC. The aim of the present study was to determine the potential diagnostic capabilities of salivary VOCs in OC through identifying and comparing the salivary volatilomic profiles among OSCC and OPMD subjects, as well as healthy controls, using the gas chromatography-mass spectrometry (GC-MS) analysis. Unstimulated saliva samples were collected from 35 OSCC subjects, 35 OPMD subjects and 40 healthy controls. The VOCs extracted from the ZSM-5/PDMS film were condensed with 100 μL of methanol, of which 1.0 μL was subjected to the GC-MS analysis. A total of 128 salivary VOCs were detected and identified among the OSCC and OPMD subjects and the healthy controls. Twenty-five metabolites were determined to be statistically significant in differentiating among the 3 groups. Organic acids, alcohols, ketones, alkanes, and acid amides were the major classes of VOCs in the OSCC subjects, while organic acids, alcohols, ketones, acid amides, heterocyclic compounds, and phenols constituted the VOC profile in the OPMD subjects. 1-chloro-dodecane and 1-tridecanol were significant VOCs observed among the controls. The study demonstrates that salivary VOC profiling can reveal distinct metabolomic alterations in OSCC and OPMDs, with several VOCs emerging as potential tumor-specific biomarkers. While these findings highlight the promise of VOC-based screening, larger studies are needed to validate these markers and establish their clinical applicability.
- 1 December 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (6) , 588-590
Association of OLP and thyroid disorder: Case report and review of literature
- 1 December 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (6) , 588-590
Association of OLP and thyroid disorder: Case report and review of literature
- 13 September 2019
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 21 (4) , 1-4
Postural Disharmony Causing Myofacial Pain: A Case Report and Review of Literature of the Treatment
Myofacial pain, a chronic painful condition of muscle origin, has numerous precipitating factors, if undiagnosed or left untreated could lead to compromised function and poor quality of life. In this case report, a female patient giving a history of 10 years of pain in the head and neck region was eventually diagnosed with myofacial pain secondary to bowing posture. The patient was successfully treated with combination of treatment modalities (TENS therapy, exercises, occlusal splint, etc.), which resulted in relief from chronic pain and improvement in quality of life.
- 13 September 2019
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 21 (4) , 1-4
Postural Disharmony Causing Myofacial Pain: A Case Report and Review of Literature of the Treatment
Myofacial pain, a chronic painful condition of muscle origin, has numerous precipitating factors, if undiagnosed or left untreated could lead to compromised function and poor quality of life. In this case report, a female patient giving a history of 10 years of pain in the head and neck region was eventually diagnosed with myofacial pain secondary to bowing posture. The patient was successfully treated with combination of treatment modalities (TENS therapy, exercises, occlusal splint, etc.), which resulted in relief from chronic pain and improvement in quality of life.
- 1 September 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (4) , 326-331
Assessment of salivary endothelin-1 in patients with leukoplakia, submucous fibrosis, oral cancer and healthy individuals – a comparative study
- 1 September 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (4) , 326-331
Assessment of salivary endothelin-1 in patients with leukoplakia, submucous fibrosis, oral cancer and healthy individuals – a comparative study
- 1 April 2019
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 9 (2) , 215-220
Spectrum of features in Darier’s disease: A case report with emphasis on differential diagnosis
- 1 April 2019
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 9 (2) , 215-220
Spectrum of features in Darier’s disease: A case report with emphasis on differential diagnosis
- 1 December 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 24, 280-285
Clinical evaluation of photodynamic therapy for the treatment of refractory oral Lichen planus – A case series
- 1 December 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 24, 280-285
Clinical evaluation of photodynamic therapy for the treatment of refractory oral Lichen planus – A case series
- Open Access
- 22 June 2018
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 7 (7) , 1432-1436
An analgesic to bridge the gap between Narcotics and NSAIDs: opiorphin
Pain management is an all-time challenge in dentistry. Discontent to pain management is a concern among patients and professionals. Unrelieved pain affects physical and mental well-being contributing to delayed recovery, psychological distress and anxiety. Studies have revealed that chronic pain interferes with normal daily chores of the individual like exercise, sleep, social life and lifestyle. At one end of pain management spectrum are Non-steroidal anti-inflammatory drugs (NSAIDs) while at the other end are the opioids. These drugs are not without constituent side effects. The quest is for new analgesics with potent and long term analgesia with minimal or no side effects. An analgesic that is intermediate in this spectrum is the need of the hour. Opiorphin is an endogenous peptide isolated from human saliva. Opiorphin produces analgesia, by inhibiting enkephalin (ENK) metabolizing enzymes, thus increasing the half-life of circulating ENKs. Apart from being a potent analgesic it can also be a potential biomarker for various systemic and psychosocial disorders. This review focuses on the pharmacological effects of opiorphin and its potential role as a biomarker in various disease conditions.
- 22 June 2018
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 7 (7) , 1432-1436
Open AccessAn analgesic to bridge the gap between Narcotics and NSAIDs: opiorphin
Pain management is an all-time challenge in dentistry. Discontent to pain management is a concern among patients and professionals. Unrelieved pain affects physical and mental well-being contributing to delayed recovery, psychological distress and anxiety. Studies have revealed that chronic pain interferes with normal daily chores of the individual like exercise, sleep, social life and lifestyle. At one end of pain management spectrum are Non-steroidal anti-inflammatory drugs (NSAIDs) while at the other end are the opioids. These drugs are not without constituent side effects. The quest is for new analgesics with potent and long term analgesia with minimal or no side effects. An analgesic that is intermediate in this spectrum is the need of the hour. Opiorphin is an endogenous peptide isolated from human saliva. Opiorphin produces analgesia, by inhibiting enkephalin (ENK) metabolizing enzymes, thus increasing the half-life of circulating ENKs. Apart from being a potent analgesic it can also be a potential biomarker for various systemic and psychosocial disorders. This review focuses on the pharmacological effects of opiorphin and its potential role as a biomarker in various disease conditions.
- 22 May 2018
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 7 (6) , 1052-1056
Cure from the rhizomes: the medicine behind the Indian saffron Curcumin
Indian system of medicine has always focused on cure from the nature. Plant products from the Indian household have been used as medicine to cure myriad of ailments since ancestral times. Curcumin is a polyphenol, an active ingredient found in turmeric. In Southeast Asia, turmeric has been used as a coloring, flavoring and as a therapeutic agent. The use of turmeric to treat ailments dates back to the times of Charaka and Shushrutha. It has been widely used as an antiseptic for cuts, burns, and bruises, and as an antibacterial agent. Modern medicine has begun to understand its importance in recent times. Unfortunately its poor solubility, limited absorption and enhanced metabolism limits its bioavailability for its extended therapeutic use. Integration of nanotechnology in drug design and development has led the way to development of nanocurcumin with improved pharmacological properties. A precise understanding of effective dose, safety, and mechanism of action is required for the rational use of turmeric in the treatment of human diseases. This review focuses on the molecular actions of curcumin and its possibility to be used as a therapeutic agent in conditions affecting oral mucosa.
- 22 May 2018
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 7 (6) , 1052-1056
Cure from the rhizomes: the medicine behind the Indian saffron Curcumin
Indian system of medicine has always focused on cure from the nature. Plant products from the Indian household have been used as medicine to cure myriad of ailments since ancestral times. Curcumin is a polyphenol, an active ingredient found in turmeric. In Southeast Asia, turmeric has been used as a coloring, flavoring and as a therapeutic agent. The use of turmeric to treat ailments dates back to the times of Charaka and Shushrutha. It has been widely used as an antiseptic for cuts, burns, and bruises, and as an antibacterial agent. Modern medicine has begun to understand its importance in recent times. Unfortunately its poor solubility, limited absorption and enhanced metabolism limits its bioavailability for its extended therapeutic use. Integration of nanotechnology in drug design and development has led the way to development of nanocurcumin with improved pharmacological properties. A precise understanding of effective dose, safety, and mechanism of action is required for the rational use of turmeric in the treatment of human diseases. This review focuses on the molecular actions of curcumin and its possibility to be used as a therapeutic agent in conditions affecting oral mucosa.